- Home
- FANG vs HLN Comparison
FANG vs HLN Comparison
Compare FANG & HLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FANG
- HLN
- Stock Information
- Founded
- FANG 2007
- HLN 2022
- Country
- FANG United States
- HLN United Kingdom
- Employees
- FANG N/A
- HLN N/A
- Industry
- FANG Oil & Gas Production
- HLN Package Goods/Cosmetics
- Sector
- FANG Energy
- HLN Consumer Discretionary
- Exchange
- FANG Nasdaq
- HLN Nasdaq
- Market Cap
- FANG 38.9B
- HLN 45.6B
- IPO Year
- FANG 2012
- HLN N/A
- Fundamental
- Price
- FANG $137.89
- HLN $10.74
- Analyst Decision
- FANG Strong Buy
- HLN Buy
- Analyst Count
- FANG 21
- HLN 1
- Target Price
- FANG $197.86
- HLN $10.95
- AVG Volume (30 Days)
- FANG 2.4M
- HLN 15.2M
- Earning Date
- FANG 05-05-2025
- HLN 02-27-2025
- Dividend Yield
- FANG 3.80%
- HLN 1.56%
- EPS Growth
- FANG N/A
- HLN 38.94
- EPS
- FANG 16.37
- HLN 0.20
- Revenue
- FANG $12,286,000,000.00
- HLN $14,062,871,660.00
- Revenue This Year
- FANG $39.37
- HLN $4.78
- Revenue Next Year
- FANG N/A
- HLN $4.75
- P/E Ratio
- FANG $8.42
- HLN $27.01
- Revenue Growth
- FANG 46.77
- HLN N/A
- 52 Week Low
- FANG $114.00
- HLN $8.12
- 52 Week High
- FANG $214.50
- HLN $10.80
- Technical
- Relative Strength Index (RSI)
- FANG 51.00
- HLN 60.96
- Support Level
- FANG $127.75
- HLN $10.57
- Resistance Level
- FANG $137.00
- HLN $10.85
- Average True Range (ATR)
- FANG 4.02
- HLN 0.14
- MACD
- FANG 0.92
- HLN 0.05
- Stochastic Oscillator
- FANG 82.78
- HLN 87.21
About FANG Diamondback Energy Inc.
Diamondback Energy is an independent oil and gas producer in the United States. The company operates exclusively in the Permian Basin. At the end of 2024, the company reported net proven reserves of 3.6 billion barrels of oil equivalent. Net production averaged about 598,000 barrels per day in 2024, at a ratio of 56% oil, 23% natural gas liquids, and 21% natural gas.
About HLN Haleon plc (Each representing two)
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.